Cargando…
A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii
Vaccine discovery against eukaryotic parasites is not trivial as highlighted by the limited number of known vaccines compared to the number of protozoal diseases that need one. Only three of 17 priority diseases have commercial vaccines. Live and attenuated vaccines have proved to be more effective...
Autores principales: | Goodswen, Stephen J., Kennedy, Paul J., Ellis, John T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201501/ https://www.ncbi.nlm.nih.gov/pubmed/37217589 http://dx.doi.org/10.1038/s41598-023-34863-9 |
Ejemplares similares
-
A Gene-Based Positive Selection Detection Approach to Identify Vaccine Candidates Using Toxoplasma gondii as a Test Case Protozoan Pathogen
por: Goodswen, Stephen J., et al.
Publicado: (2018) -
Systematic identification of the lysine lactylation in the protozoan parasite Toxoplasma gondii
por: Zhao, Wei, et al.
Publicado: (2022) -
MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii
por: Kelsen, Anne, et al.
Publicado: (2023) -
Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology
por: Goodswen, Stephen J., et al.
Publicado: (2014) -
Transcriptional regulation of two stage-specifically expressed genes in the protozoan parasite Toxoplasma gondii
por: Kibe, Michael K., et al.
Publicado: (2005)